SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-13-007138
Filing Date
2013-08-22
Accepted
2013-08-21 20:18:00
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2023519
2 GRAPHIC g528268g97l39.jpg GRAPHIC 21369
3 GRAPHIC g528268g14o39.jpg GRAPHIC 35863
4 GRAPHIC g528268g60t13.jpg GRAPHIC 63601
5 GRAPHIC g528268g68v84.jpg GRAPHIC 48780
6 GRAPHIC g528268g73h83.jpg GRAPHIC 28158
7 GRAPHIC g528268g75o28.jpg GRAPHIC 35728
8 GRAPHIC g528268g78f54.jpg GRAPHIC 15149
9 GRAPHIC g528268g79y39.jpg GRAPHIC 61881
10 GRAPHIC g528268g90f76.jpg GRAPHIC 34091
  Complete submission text file 0000950123-13-007138.txt   2500723
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE
Type: DRS/A | Act: 33 | File No.: 377-00182 | Film No.: 131053959
SIC: 2836 Biological Products, (No Diagnostic Substances)